UNITED STATES ~~SECURITIES AND EXCHANGE COMMISSION~~

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 ORor 15(d) of The Securities Exchange Act of 1934

~~The~~Date ~~Securities~~of ~~Exchange~~Report ~~Act~~(Date of ~~1934~~earliest event reported): August 12, 2011

~~Date~~ITECH ~~of Report (Date of earliest event reported): August 9~~MEDICAL, ~~2011 (June 20, 2011)~~INC.

iTech Medical, Inc.

(Exact name of registrant as specified in its charter)

Delaware	000-52117	20-5153331
(State of other jurisdiction	(Commission	(IRS Employer
(State or Other Jurisdiction of	(Commission File Number)	(IRS Employer
of incorporation)	File Number)	Identification No.)
Incorporation)		Identification No.)
	17011 Beach Boulevard Suite 900 Huntington Beach, California 92647
	(Address of principal executive offices)

~~Registrant’s~~17011 ~~telephone~~Beach ~~number~~Boulevard, ~~including~~Suite ~~area~~900 ~~code:~~Huntington Beach, California 92647 92647 (~~714~~Zip Code) ~~841-2670~~(Address of Principal Executive Offices)

~~Not~~(714) ~~Applicable~~841-2670

(~~Former~~Registrant’s ~~name~~telephone ~~or former address~~number, ifincluding ~~changed~~area ~~since last report.~~code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

~~Item~~¨ ~~5.02~~Soliciting ~~Departure~~material ofpursuant ~~Directors~~to orRule ~~Certain~~14a-12 ~~Officers;~~under ~~Election~~the ofExchange ~~Directors;~~Act ~~Appointment~~(17 ofCFR ~~Certain Officers; Compensatory Arrangements of Certain Officers~~240.14a-12)

On¨ ~~June~~Pre-commencement ~~20,~~communications ~~2011,~~pursuant ~~the~~to ~~resignations~~Rule ~~were accepted from George Angelidis, Wayne Cockburn and Donald Paterson from the Board of Directors of iTech Medical, Inc.~~ 14d-2(~~the “Company”~~b)~~. The~~ ~~resignations were tendered in connection with the Stipulation as described in more detail~~ under ~~Item 8.01 of this Form 8-K. Remaining on~~ the ~~Board~~Exchange ofAct ~~Directors~~(17 ~~are~~CFR ~~President and CEO, Warren G~~240. ~~Baker, and Director Wim Peters.~~14d-2(b))

On¨ ~~and~~Pre-commencement ~~effective~~communications ~~June~~pursuant ~~21,~~to ~~2011,~~Rule ~~Wayne~~13e-4(c) ~~Cockburn~~under ~~resigned~~the asExchange ~~Chief~~Act ~~Financial~~(17 ~~Officer~~CFR ~~and Secretary of the Company~~240.13e-4(c))

OnItem ~~July 18, 2011, Dr~~8. ~~Alan Goldman, Vice President of Clinical Affairs and Mr~~01. ~~Steeve~~ ~~Asselin,~~Other ~~Vice President of Research and Development, resigned from their offices effective as of that date.~~Events

On ~~July~~August 2512, 2011, ~~the~~iTech ~~Company~~Medical, ~~announced~~Inc. ~~two~~(the ~~new~~“Company”) ~~members~~issued toa ~~the~~press ~~Board~~release ofannouncing ~~Directors,~~its ~~Mr.~~intent ~~Robert~~to ~~Gradus~~voluntarily ~~and~~deregister ~~Ms.~~its ~~Karin~~common ~~Monster~~stock tounder ~~fill~~ the ~~vacancies~~Securities ~~created~~Exchange byAct ~~the resignation~~ of ~~Messrs. Angelidis~~1934, ~~Cockburn,~~as ~~and Paterson~~amended. In ~~addition,~~A copy of the ~~Company~~press ~~appointed~~release ~~Mr.~~is ~~Gradus~~attached as ~~the~~Exhibit ~~Chief~~99.1 ~~Financial~~to ~~Officer~~this ofCurrent ~~the~~Report ~~Company~~on Form 8-K.

~~Mr.~~Item ~~Robèrt Gradus, age 47, studied construction and management at the University of Eindhoven in the Netherlands and completed the General Management Programme, Insead, at Cedep in Fontainebleau France~~9. ~~Prior to joining the Company, Mr Gradus was the Division Director of Heijmans N~~01.~~V., a company that can be found on the AEX-Index.~~ ~~Currently,~~Financial heStatements ~~is a director at Oskomera Group in the Netherlands, an international company in steel-, facade-~~ and solar systems. Additionally, Mr. Gradus serves on various corporate boards and owns the strategic consulting company, Farcha B.V., where he advises senior management on such issues as; interim-management, finance, investments and change management.Exhibits

~~Mrs. Karin Monster, age 32, joins iTech after a 2 year sabbatical and is currently employed at Stako B.V. in the Netherlands as a Business Process Manager.~~(c) Her educational background includes a Master’s Degree in Gifted Education while studying Educational and Behavioral Sciences at Radboud University in the Netherlands. Previously, from 2005 through 2009, Mrs. Monster was a Chair-person or Director of several prestigious organizations includingExhibits: Chair-person of the Facta Foundation, which created and sponsored educational projects for gifted children, Director of Samen voor Zorg, a private practice of educational and behavioral therapists and Vice Chair-person of the Leonardo Foundation that supports schools and advocates for gifted educational programs.

There is no family relationship between Messrs. Baker, Peters, and Gradus, and Mrs. Monster, and any of the Company’s officers and directors with the exception that Mrs. Monster is the daughter-in-law of Mr. Peters.

Exhibit No.	Description

99.1	Press Release, dated August 12, 2011

~~There are presently no compensation arrangements with Mr. Gradus and Ms. Monster.~~SIGNATURE

~~Item~~ Pursuant ~~8.01~~to ~~Other~~the ~~Events~~requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

In June, 2011, a complaint captioned, Augustinus Petms Johannes Franciscus “Guus” Peeters v. Itech Medical, Inc., et al, CA No. 6538-VCN, was filed in the Court of Chancery in the State of Delaware (“Litigation”). On June 16, 2011, the parties to the Litigation entered into a Stipulation (the “Stipulation”) to resolve the Litigation in its entirety. The Stipulation provided for (i) the immediate resignation of Messrs. George Angelidis, Wayne Cockburn, and Donald Paterson as directors, (ii) for the Board to fix the number of directors to five (5), and to prepare proxy materials containing the slate of five directors consisting of Warren G. Baker, Wim Peters, Robert A.M.M. Gradus, Bikash K. Chatterjee, and Katerina Monster. The Court approved the Stipulation on June 20, 2011 and the Litigation has been dismissed with prejudice. A copy of the Stipulation is attached as an exhibit.

	iTech Medical, Inc.
	a Delaware Corporation

Dated: August 12, 2011	/s/ Warren G. Baker
	Warren G. Baker, Chief Executive Officer

Item 9.01 Financial Statements and Exhibits

(d) Exhibits.

Exhibit No.		Description
99.1		Stipulation dated June 20, 2011
99.2		Resignation from Wayne Crockburn
99.3		Press Release dated June 20, 2011
99.4		Press Release dated August 9, 2011

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: August 9, 2011	iTech Medical, Inc.
	By:	/s/ Warren G. Baker
		Warren G. Baker President, Chief Executive Officer

Filing Compare · iTech Medical, Inc.